SAB Biotherapeutics, Inc. Common Stock — Quarterly Financial Statements (NASDAQ:SABSW) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Market Capitalization 43.708 M
Employee 63
Founded 2014
CEO N/A
Website www.sab.bio
Headquarter Delaware, United States
FIGI BBG00YHY0G24
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

43.71 M Market capitalization

Price to earnings ratio

-0.01

Price to sales ratio

1.26

Dividends per share

—

Dividend yield %

—